Physiopathology of acute renal failure during sepsis;Fisiopatología de la insuficiencia renal aguda durante la sepsis

Medicina Intensiva

Volumn 35, Issue 7, 2011, Pages 424-432

  Regueira, T ^a   Andresen, M ^a   Mercado, M ^a   Downey, P ^a  

^a Rheumatology Service   (Chile)

Author keywords

Acute renal failure; Renal blood flow; Sepsis

Indexed keywords

ACUTE KIDNEY FAILURE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART OUTPUT; HEMODYNAMICS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY TUBULE NECROSIS; MICROCIRCULATION; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEPSIS; SHORT SURVEY;

ACUTE KIDNEY INJURY; APOPTOSIS; CARDIAC OUTPUT; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION MEDIATORS; ISCHEMIA; KIDNEY; MICROCIRCULATION; MITOCHONDRIA; OXIDATIVE STRESS; RENAL CIRCULATION; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; SEPSIS; THROMBOPHILIA; VASODILATION;

EID: 80052264436     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2011.03.011     Document Type: Short Survey

References (98)

1. Ostermann M., Chang R.W. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007, 35:1837-1843. quiz 1852.
2. Uchino S., Kellum J.A., Bellomo R., Doig G.S., Morimatsu H., Morgera S., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
3. Herrera-Gutierrez M.E., Seller-Perez G., Maynar-Moliner J., Sanchez-Izquierdo-Riera J.A. Epidemiology of acute kidney failure in Spanish ICU. Multicenter prospective study FRAMI. Med Intensiva 2006, 30:260-267.
4. Bellomo R., Ronco C., Kellum J.A., Mehta Rl, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-212.
5. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
6. Uchino S., Bellomo R., Goldsmith D., Bates S., Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006, 34:1913-1917.
7. Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
8. Robert A.M., Kramer R.S., Dacey L.J., Charlesworth D.C., Leavitt B.J., Helm R.E., et al. Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria. Ann Thorac Surg 2010, 90:1939-1943.
9. Joannidis M., Metnitz B., Bauer P., Schusterschitz N., Moreno R., Druml W., et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009, 35:1692-1702.
10. Regueira T., Andresen M. Management of oxygen delivery and consumption during sepsis. Rev Med Chil 2010, 138:233-242.
11. Bellomo R., Chapman M., Finfer S., Hickling K., Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356:2139-2143.
12. Heyman S.N., Lieberthal W., Rogiers P., Bonventre J.V. Animal models of acute tubular necrosis. Curr Opin Crit Care 2002, 8:526-534.
13. Wan L., Bellomo R., Di Giantomasso D., Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003, 9:496-502.
14. Kikeri D., Pennell J.P., Hwang K.H., Jacob A.I., Richman A.V., Bourgoignie J.J. Endotoxemic acute renal failure in awake rats. Am J Physiol 1986, 250:F1098-1106.
15. Badr K.F., Kelley V.E., Rennke H.G., Brenner B.M. Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int 1986, 30:474-480.
16. Zanotti-Cavazzoni Sl, Goldfarb R.D. Animal models of sepsis. Crit Care Clin 2009, 25:703-719. vii-viii.
17. Langenberg C., Bellomo R., May C., Wan L., Egi M., Morgera S. Renal blood flow in sepsis. Crit Care 2005, 9:R363-374.
18. Langenberg C., Wan L., Egi M., May C.N., Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int 2006, 69:1996-2002.
19. Ravikant T., Lucas C.E. Renal blood flow distribution in septic hyperdynamic pigs. J Surg Res 1977, 22:294-298.
20. Brenner M., Schaer G.L., Mallory D.L., Suffredini A.F., Parrillo J.E. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990, 98:170-179.
21. Langenberg C., Bagshaw S.M., May C.N., Bellomo R. The histopathology of septic acute kidney injury: a systematic review. Crit Care 2008, 12:R38.
22. Lerolle N., Nochy D., Guerot E., Bruneval P., Fagon J.Y., Diehl J.L., et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 2010, 36:471-478.
23. Doi K., Leelahavanichkul A., Yuen P.S., Star R.A. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 2009, 119:2868-2878.
24. Fink M.P., Delude R.L. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 2005, 21:177-196.
25. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996, 98:2854-2865.
26. Kaushal G.P., Basnakian A.G., Shah S.V. Apoptotic pathways in ischemic acute renal failure. Kidney Int 2004, 66:500-506.
27. Langenberg C., Wan L., Egi M., May C.N., Bellomo R. Renal blood flow and function during recovery from experimental septic acute kidney injury. Intensive Care Med 2007, 33:1614-1618.
28. Spain D.A., Wilson M.A., Garrison R.N. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 1994, 116:322-330. discussion 330-321.
29. Brezis M., Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995, 332:647-655.
30. Di Giantomasso D., Morimatsu H., May C.N., Bellomo R. Intrarenal blood flow distribution in hyperdynamic septic shock: Effect of norepinephrine. Crit Care Med 2003, 31:2509-2513.
31. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003, 31:S195-199.
32. Marshall J.C., Vincent J.L., Fink M.P., Cook D.J., Rubenfeld G., Foster D., et al. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003, 31:1560-1567.
33. Camussi G., Ronco C., Montrucchio G., Piccoli G. Role of soluble mediators in sepsis and renal failure. Kidney Int Suppl 1998, 66:S38-42.
34. Knotek M., Rogachev B., Wang W., Ecder T., Melnikov V., Gengaro P.E., et al. Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 2001, 59:2243-2249.
35. Cunningham P.N., Dyanov H.M., Park P., Wang J., Newell K.A., Quigg R.J. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002, 168:5817-5823.
36. Rodriguez-Wilhelmi P., Montes R., Matsukawa A., Nariuchi H., Hurtado V., Montes M., et al. Tumor necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock. J Lab Clin Med 2003, 141:257-264.
37. Thijs A., Thijs L.G. Pathogenesis of renal failure in sepsis. Kidney Int Suppl 1998, 66:S34-S37.
38. Messmer U.K., Briner V.A., Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 1999, 55:2322-2337.
39. Andresen H.M., Regueira H.T., Leighton F. Oxidative stress in critically ill patients. Rev Med Chil 2006, 134:649-656.
40. Wang W., Jittikanont S., Falk S.A., Li P., Feng L., Gengaro P.E., et al. Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 2003, 284:F532-537.
41. Himmelfarb J., Mcmonagle E., Freedman S., Klenzak J., Mcmenamin E., Le P., et al. Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 2004, 15:2449-2456.
42. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003, 299:896-899.
43. Petros A., Lamb G., Leone A., Moncada S., Bennett D., Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994, 28:34-39.
44. Radi R., Cassina A., Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol Chem 2002, 383:401-409.
45. Kantrow S.P., Taylor D.E., Carraway M.S., Piantadosi C.A. Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch Biochem Biophys 1997, 345:278-288.
46. Unno N., Wang H., Menconi M.J., Tytgat S.H., Larkin V., Smith M., et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997, 113:1246-1257.
47. Zingarelli B., Day B.J., Crapo J.D., Salzman A.L., Szabo C. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997, 120:259-267.
48. Brealey D., Karyampudi S., Jacques T.S., Novelli M., Stidwill R., Taylor V., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004, 286:R491-497.
49. Radi R., Rodriguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994, 308:89-95.
50. Murray A.J., Anderson R.E., Watson G.C., Radda G.K., Clarke K. Uncoupling proteins in human heart. Lancet 2004, 364:1786-1788.
51. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
52. Goode H.F., Cowley H.C., Walker B.E., Howdle P.C., Webster N.R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995, 23:646-651.
53. Takeda K., Shimada Y., Amano M., Sakai T., Okada T., Yoshiya I. Plasma lipid peroxides and alpha-tocopherol in critically ill patients. Crit Care Med 1984, 12:957-959.
54. Andresen M., Regueira T., Bruhn A., Perez D., Strobel P., Dougnac A., et al. Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock. Mediators Inflamm 2008, 168652.
55. Deneke S.M., Lynch B.A., Fanburg B.L. Effects of low protein diets or feed restriction on rat lung glutathione and oxygen toxicity. J Nutr 1985, 115:726-732.
56. Messmer U.K., Briner V.A., Pfeilschifter J. Basic fibroblast growth factor selectively enhances TNF-alpha-induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J Am Soc Nephrol 2000, 11:2199-2211.
57. Elbers P.W., Ince C. Mechanisms of critical illness - classifying microcirculatory flow abnormalities in distributive shock. Crit Care 2006, 10:221.
58. Regueira T., Andresen M., Djafarzadeh S. Mitochondrial dysfunction during sepsis, impact and possible regulating role of hypoxia-inducible factor-1alpha. Med Intensiva 2009, 33:385-392.
59. Szabo C. Poly (ADP-ribose) polymerase activation and circulatory shock. Novartis Found Symp 2007, 280:92-103. discussion 103-107, 160-104.
60. Goldfarb R.D., Marton A., Szabo E., Virag L., Salzman A.L., Glock D., et al. Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 2002, 30:974-980.
61. Larche J., Lancel S., Hassoun S.M., Favory R., Decoster B., Marchetti P., et al. Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. J Am Coll Cardiol 2006, 48:377-385.
62. Regueira T., Lepper P.M., Brandt S., Ochs M., Vuda M., Takala J., et al. Hypoxia inducible factor-1 alpha induction by tumour necrosis factor-alpha, but not by toll-like receptor agonists, modulates cellular respiration in cultured human hepatocytes. Liver Int 2009, 29:1582-1592.
63. Vary T.C. Increased pyruvate dehydrogenase kinase activity in response to sepsis. Am J Physiol 1991, 260:E669-E674.
64. Vary T.C., Siegel J.H., Nakatani T., Sato T., Aoyama H. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 1986, 250:E634-640.
65. Crouser E.D., Julian M.W., Huff J.E., Struck J., Cook C.H. Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med 2006, 34:2439-2446.
66. Fredriksson K., Hammarqvist F., Strigard K., Hultenby K., Ljungqvist O., Wernerman J., et al. Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab 2006, 291:E1044-1050.
67. Porta F., Takala J., Weikert C., Bracht H., Kolarova A., Lauterburg B.H., et al. Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function. Crit Care 2006, 10:R118.
68. Kozlov A.V., Van Griensven M., Haindl S., Kehrer I., Duvigneau J.C., Hartl R.T., et al. Peritoneal inflammation in pigs is associated with early mitochondrial dysfunction in liver and kidney. Inflammation 2010, 33:295-305.
69. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-8.
70. Imai Y., Parodo J., Kajikawa O., De Perrot M., Fischer S., Edwards V., et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003, 289:2104-2112.
71. Mishra J., Ma Q., Prada A., Mitsnefes M., Zahedi K., Yang J., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003, 14:2534-2543.
72. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004, 24:307-315.
73. Haase M., Haase-Fielitz A., Bellomo R., Mertens P.R. Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease. Curr Opin Hematol 2011, [Published ahead of print].
74. Martensson J., Bell M., Oldner A., Xu S., Venge P., Martling C.R. Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010, 36:1333-1340.
75. Cruz D.N., De Cal M., Garzotto F., Perazella M.A., Lentini P., Corradi V., et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010, 36:444-451.
76. Siew E.D., Ware L.B., Gebretsadik T., Shintani A., Moons K.G., Wickersham N., et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 2009, 20:1823-1832.
77. Melnikov V.Y., Faubel S., Siegmund B., Lucia M.S., Ljubanovic D., Edelstein C.L. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 2002, 110:1083-1091.
78. Parikh C.R., Mishra J., Thiessen-Philbrook H., Dursun B., Ma Q., Kelly C., et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006, 70:199-203.
79. Parikh C.R., Abraham E., Ancukiewicz M., Edelstein C.L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005, 16:3046-3052.
80. Liangos O., Perianayagam M.C., Vaidya V.S., Han W.K., Wald R., Tighiouart H., et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:904-912.
81. Mehta Rl, Mcdonald B., Gabbai F.B., Pahl M., Pascual M.T., Farkas A., et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001, 60:1154-1163.
82. Lins R.L., Elseviers M.M., Van der Niepen P., Hoste E., Malbrain M.L., Damas P., et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant 2009, 24:512-518.
83. Augustine J.J., Sandy D., Seifert T.H., Paganini E.P. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004, 44:1000-1007.
84. Bagshaw S.M., Berthiaume L.R., Delaney A., Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 2008, 36:610-617.
85. Pannu N., Klarenbach S., Wiebe N., Manns B., Tonelli M. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008, 299:793-805.
86. Tetta C., Bellomo R., Ronco C. Artificial organ treatment for multiple organ failure, acute renal failure, and sepsis: recent new trends. Artif Organs 2003, 27:202-213.
87. Honore P.M., Matson J.R. Extracorporeal removal for sepsis: Acting at the tissue level - the beginning of a new era for this treatment modality in septic shock. Crit Care Med 2004, 32:896-897.
88. Di Carlo J.V., Alexander S.R. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs 2005, 28:777-786.
89. Honore P.M., Joannes-Boyau O. High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004, 27:1077-1082.
90. Cole L., Bellomo R., Journois D., Davenport P., Baldwin I., Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001, 27:978-986.
91. Romero C.M., Downey P., Hernandez G. High volume hemofiltration in septic shock. Med Intensiva 2010, 34:345-352.
92. Cornejo R., Downey P., Castro R., Romero C., Regueira T., Vega J., et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006, 32:713-722.
93. Boussekey N., Chiche A., Faure K., Devos P., Guery B., D'Escrivan T., et al. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008, 34:1646-1653.
94. Ruiz C, Hernandez G, Godoy C, Downey P, Andresen M, Bruhn A. Sublingual microcirculatory changes during high-volume hemofiltration in hyperdynamic septic shock patients. Crit Care. 2010;14:R170.
95. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007;CD003773.
96. Vinsonneau C., Camus C., Combes A., Costa de Beauregard M.A., Klouche K., Boulain T., et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet 2006, 368:379-385.
97. Baeza-Roman A., Latour-Perez J., Gomez-Tello V., Garcia-Garcia M.A. Hemofiltration in sepsis: what is the evidence?. Med Intensiva 2010, 34:571-572. author reply 572-3.
98. Phu N.H., Hien T.T., Mai N.T., Chau T.T., Chuong L.V., Loc P.P., et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002, 347:895-902.